
In this white paper, we explore the current landscape of proteomics technologies. These include mass spectrometry-based proteomics, affinity-based proteomics, peptide sequencing, and our own Iterative Mapping. We highlight the fundamental strengths and weaknesses of these technologies, framed in terms of coverage — the ability to detect every protein in the proteome — and detail — the ability to confidently measure the abundance of every detected protein as well as the ability to quantify proteoforms.
We further invite readers to work with us to learn how they can use Iterative Mapping in their research.

Copyright © 2026 American Chemical Society | 1155 Sixteenth Street NW | Washington, DC 20036 | View our Privacy Policy